drugset / Trial / NCT03755778
Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects
Phase 1
Completed
72 enrolled
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates · collab
Non-randomizedSingle-groupOpen-labelBasic science
Summary
A Non-Randomized, Open-Label, Three-Part, Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Rifampin, and Quinidine on the Pharmacokinetics and Safety of EDP-938 in Healthy Subjects
Timeline
- Start
- 2018-11-29
- Primary completion
- 2019-01-21
- Completion
- 2019-01-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | — | — |
| Subject | Quinidine | Small molecule | — | — |
| Subject | Rifampin | Small molecule | — | — |
| Subject | zelicapavir | Small molecule | — | — |